# BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

> **NCT02324309** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biodel** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** BIOD-531
- **DRUG:** Humalog Mix 75/25
- **DRUG:** Humulin R U-500
- **DRUG:** BIOD-531

## Key facts

- **NCT ID:** NCT02324309
- **Lead sponsor:** Biodel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324309, "BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02324309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*